Behavioral Artificial Intelligence To Improve Patient Adherence & Engagement In Programs Pre- & Post-Transplant

Overview

About this study

The purpose of this study is to improve patient pre-transplant readiness and adherence to posttransplant rehabilitation such as adherence to post-transplant medications, diet and exercise.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Key Inclusion Criteria:

  • Adult patients aged 18 years or older.

  • Post-orthotopic liver transplant recipient at Mayo Clinic Arizona.

  • Able to provide electronic informed consent.

  • English proficiency sufficient to provide a 100-300 word natural language sample.

  • Consent for language sampling, RUO AlloSure-Liver testing, alcohol biomarker data collection, medication adherence data collection, and EHR outcome analysis.

Key Exclusion Criteria:

  • Dual-organ or multi-organ transplant recipients, unless Mayo and CareDx approve inclusion for non-AlloSure analyses in a future amendment.

  • Previous allogeneic bone marrow transplant recipient.

  • Pregnant patients or patients who become pregnant following liver transplantation, unless Mayo determines that continued data collection is appropriate and permitted.

  • Severe cognitive impairment that prevents informed consent or meaningful participation in language sampling.

  • Non-fluent English speaker.

  • Unwilling to participate or unwilling to permit required data collection and sharing.

  • Any Mayo Clinic Arizona transplant exclusion criterion that makes participation inappropriate in the judgment of the clinical team.

 

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 06/16/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Contact us for the latest status

Contact information:

Amy Holloway

(480) 342-2906

holloway.amy@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20609354

Mayo Clinic Footer